BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37290592)

  • 1. Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics.
    Uzun S; Zinner CP; Beenen AC; Alborelli I; Bartoszek EM; Yeung J; Calgua B; Reinscheid M; Bronsert P; Stalder AK; Haslbauer JD; Vosbeck J; Mazzucchelli L; Hoffmann T; Terracciano LM; Hutter G; Manz M; Panne I; Boettler T; Hofmann M; Bengsch B; Heim MH; Bernsmeier C; Jiang S; Tzankov A; Terziroli Beretta-Piccoli B; Matter MS
    J Hepatol; 2023 Sep; 79(3):666-676. PubMed ID: 37290592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis.
    Boettler T; Csernalabics B; Salié H; Luxenburger H; Wischer L; Salimi Alizei E; Zoldan K; Krimmel L; Bronsert P; Schwabenland M; Prinz M; Mogler C; Neumann-Haefelin C; Thimme R; Hofmann M; Bengsch B
    J Hepatol; 2022 Sep; 77(3):653-659. PubMed ID: 35461912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
    Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
    United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hepatitis after COVID-19 vaccination.
    Zheng H; Zhang T; Xu Y; Lu X; Sang X
    Front Immunol; 2022; 13():1035073. PubMed ID: 36505482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    Ghielmetti M; Schaufelberger HD; Mieli-Vergani G; Cerny A; Dayer E; Vergani D; Terziroli Beretta-Piccoli B
    J Autoimmun; 2021 Sep; 123():102706. PubMed ID: 34293683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection in patients with autoimmune hepatitis.
    Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
    J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.
    Renand A; Cervera-Marzal I; Gil L; Dong C; Garcia A; Kervagoret E; Aublé H; Habes S; Chevalier C; Vavasseur F; Clémenceau B; Cardon A; Judor JP; Mosnier JF; Tanné F; Laplaud DA; Brouard S; Gournay J; Milpied P; Conchon S
    J Hepatol; 2020 Dec; 73(6):1379-1390. PubMed ID: 32649971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury.
    Lleo A; Cazzagon N; Rigamonti C; Cabibbo G; Lai Q; Muratori L; Carbone M;
    Dig Liver Dis; 2022 Jun; 54(6):722-726. PubMed ID: 35410851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune liver diseases and SARS-CoV-2.
    Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
    World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    Efe C; Taşçılar K; Gerussi A; Bolis F; Lammert C; Ebik B; Stättermayer AF; Cengiz M; Gökçe DT; Cristoferi L; Peralta M; Massoumi H; Montes P; Cerda E; Rigamonti C; Yapalı S; Adali G; Çalışkan AR; Balaban Y; Eren F; Eşkazan T; Barutçu S; Lytvyak E; Zazueta GM; Kayhan MA; Heurgue-Berlot A; De Martin E; Yavuz A; Bıyık M; Narro GC; Duman S; Hernandez N; Gatselis NK; Aguirre J; Idilman R; Silva M; Mendizabal M; Atay K; Güzelbulut F; Dhanasekaran R; Montano-Loza AJ; Dalekos GN; Ridruejo E; Invernizzi P; Wahlin S
    J Autoimmun; 2022 Oct; 132():102906. PubMed ID: 36088883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
    Trontzas IP; Kyriakoulis KG; Vathiotis IA; Syrigos A; Kounadis G; Siasiakou S; Poulakou G
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitis.
    Hartl J; Rüther DF; Duengelhoef PM; Brehm TT; Steinmann S; Weltzsch JP; Glaser F; Sterneck M; Sebode M; Weiler-Normann C; Lütgehetmann M; Schaub GM; Haag F; Schramm C; Wiesch JSZ; Lohse AW
    Liver Int; 2023 Feb; 43(2):393-400. PubMed ID: 35840342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?
    López Romero-Salazar F; Veras Lista M; Gómez-Domínguez E; Ibarrola-Andrés C; Muñoz Gómez R; Fernández Vázquez I
    Rev Esp Enferm Dig; 2022 Sep; 114(9):567-568. PubMed ID: 35373571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.
    Codoni G; Kirchner T; Engel B; Villamil AM; Efe C; Stättermayer AF; Weltzsch JP; Sebode M; Bernsmeier C; Lleo A; Gevers TJ; Kupčinskas L; Castiella A; Pinazo J; De Martin E; Bobis I; Sandahl TD; Pedica F; Invernizzi F; Del Poggio P; Bruns T; Kolev M; Semmo N; Bessone F; Giguet B; Poggi G; Ueno M; Jang H; Elpek GÖ; Soylu NK; Cerny A; Wedemeyer H; Vergani D; Mieli-Vergani G; Lucena MI; Andrade RJ; Zen Y; Taubert R; Terziroli Beretta-Piccoli B
    JHEP Rep; 2023 Jan; 5(1):100605. PubMed ID: 36440259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine and autoimmune hepatitis.
    Sookaromdee P; Wiwanitkit V
    Rev Esp Enferm Dig; 2022 Oct; 114(10):631. PubMed ID: 35469403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
    Ueno M; Takabatake H; Itakura J; Fujita R; Kayahara T; Morimoto Y; Notohara K; Mizuno M
    Clin J Gastroenterol; 2023 Aug; 16(4):554-558. PubMed ID: 37029249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peculiarity of Autoimmune Hepatitis Triggered by SARS-CoV-2 Infection.
    Gallo A; Ibba F; Massaro MG; Rognoni F; Giustiniani MC; Ponziani FR; Montalto M
    Eur J Case Rep Intern Med; 2024; 11(1):004195. PubMed ID: 38223285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series.
    Bernasconi E; Biagi M; Di Agostino S; Cursaro C; Felicani C; Ronconi E; Franchi E; Costanzo AC; Gabrielli F; Cavicchioli A; Ienopoli G; Marenghi P; Bartoli A; Serra B; Scalabrini D; Sighinolfi P; Andreone P
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto-immune hepatitis following COVID vaccination.
    Rela M; Jothimani D; Vij M; Rajakumar A; Rammohan A
    J Autoimmun; 2021 Sep; 123():102688. PubMed ID: 34225251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.